[HTML][HTML] Soy and health update: evaluation of the clinical and epidemiologic literature
M Messina - Nutrients, 2016 - mdpi.com
Soyfoods have long been recognized as sources of high-quality protein and healthful fat, but
over the past 25 years these foods have been rigorously investigated for their role in chronic …
over the past 25 years these foods have been rigorously investigated for their role in chronic …
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials
SM Boekholdt, GK Hovingh, S Mora… - Journal of the American …, 2014 - jacc.org
Background: Levels of atherogenic lipoproteins achieved with statin therapy are highly
variable, but the consequence of this variability for cardiovascular disease risk is not well …
variable, but the consequence of this variability for cardiovascular disease risk is not well …
[HTML][HTML] A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality
RK Wadhera, DL Steen, I Khan, RP Giugliano… - Journal of clinical …, 2016 - Elsevier
Cardiovascular (CV) disease is a leading cause of death worldwide, accounting for
approximately 31.4% of deaths globally in 2012. It is estimated that, from 1980 to 2000 …
approximately 31.4% of deaths globally in 2012. It is estimated that, from 1980 to 2000 …
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
MJ Chapman, HN Ginsberg, P Amarenco… - European heart …, 2011 - academic.oup.com
Even at low-density lipoprotein cholesterol (LDL-C) goal, patients with cardiometabolic
abnormalities remain at high risk of cardiovascular events. This paper aims (i) to critically …
abnormalities remain at high risk of cardiovascular events. This paper aims (i) to critically …
Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention
J Millán, X Pintó, A Muñoz, M Zúñiga… - Vascular health and …, 2009 - Taylor & Francis
Low-density lipoprotein (LDL) cholesterol concentration has been the prime index of
cardiovascular disease risk and the main target for therapy. However, several lipoprotein …
cardiovascular disease risk and the main target for therapy. However, several lipoprotein …
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
Heart Protection Study Collaborative Group - The Lancet, 2002 - Elsevier
BACKGROUND: Throughout the usual LDL cholesterol range in Western populations, lower
blood concentrations are associated with lower cardiovascular disease risk. In such …
blood concentrations are associated with lower cardiovascular disease risk. In such …
[HTML][HTML] Impact of a 12-week high-intensity interval training without caloric restriction on body composition and lipid profile in sedentary healthy overweight/obese …
M Khammassi, N Ouerghi, S Hadj-Taieb… - Journal of exercise …, 2018 - ncbi.nlm.nih.gov
Although High-intensity interval training (HIIT) has shown its effectiveness in improving body
composition, cardio-respiratory fitness and lipid profile in obese adults, evidences remain …
composition, cardio-respiratory fitness and lipid profile in obese adults, evidences remain …
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
HB Rubins, SJ Robins, D Collins, CL Fye… - … England Journal of …, 1999 - Mass Medical Soc
Background Although it is generally accepted that lowering elevated serum levels of low-
density lipoprotein (LDL) cholesterol in patients with coronary heart disease is beneficial …
density lipoprotein (LDL) cholesterol in patients with coronary heart disease is beneficial …
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial
TR Pedersen, O Faergeman, JJP Kastelein, AG Olsson… - Jama, 2005 - jamanetwork.com
ContextEvidence suggests that more intensive lowering of low-density lipoprotein
cholesterol (LDL-C) than is commonly applied clinically will provide further benefit in stable …
cholesterol (LDL-C) than is commonly applied clinically will provide further benefit in stable …
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of …
JD Brunzell, M Davidson, CD Furberg… - Journal of the American …, 2008 - jacc.org
Risk factors for type 2 diabetes and cardiovascular disease (CVD) often cluster, including
obesity (particularly central), insulin resistance, hyperglycemia, dyslipoproteinemia, and …
obesity (particularly central), insulin resistance, hyperglycemia, dyslipoproteinemia, and …